Clinical Trials Browser

Phase 2/3 × Unknown × Dexmedetomidine × Clear all

NCT05340725 2023-01-23

DEX-NANO

Phase 2/3 Unknown

Pain, Postoperative

NCT04106999 2022-11-03

Dexmedetomidine and HIPEC

Phase 2/3 Unknown

Inflammation, Neoplasms

NCT02455609 2015-05-28

Intrathecal Ketamine, Dexmedetomidine and Both With Bupivacaine for Postoperative Abdominal Cancer Surgery Pain

Phase 2/3 Unknown

Agnosia, Pain, Postoperative